Back to search results

Trial of Relatlimab, Nivolumab, and Ipilimumab in Patients With Asymptomatic and Symptomatic Melanoma Brain Metastases

Abroad (travel likely)RecruitingPHASE2

Conditions

Melanoma · Brain Metastases

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Stanford University, Palo Alto, California, United States

    Contact: Study coordinator (Divya Divya Pathak) · divya22@stanford.edu · 650-492-3674
    Contact: Study coordinator (Phuong Q Pham) · ppham5@stanford.edu
    Contact: Principal Investigator (Allison Betof, MD, Phd)
Study leads

  • Allison Betof, MD, PhD

    Principal Investigator

    Stanford University

View source on ClinicalTrials.gov(opens in a new tab)